Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab? (2018)

First Author: Smith-Jackson K

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21037/atm.2018.10.35

PubMed Identifier: 30613637

Publication URI: http://europepmc.org/abstract/MED/30613637

Type: Journal Article/Review

Volume: 6

Parent Publication: Annals of translational medicine

Issue: Suppl 1

ISSN: 2305-5839